Exon-Skipping Antisense Oligonucleotides to Correct Missplicing in Neurogenetic Diseases

被引：61

作者：

Siva, Kavitha ^{[1
]}

Covello, Giuseppina ^{[1
]}

Denti, Michela A. ^{[1
,2
]}

机构：

[1] Univ Trento, Ctr Integrat Biol CIBIO, I-38123 Trento, Italy

[2] CNR, Inst Neurosci, Padua, Italy

来源：

NUCLEIC ACID THERAPEUTICS | 2014年 / 24卷 / 01期

关键词：

RESTORES DYSTROPHIN EXPRESSION; AMYLOID PRECURSOR PROTEIN; SPINAL MUSCULAR-ATROPHY; PEPTIDE NUCLEIC-ACID; PELIZAEUS-MERZBACHER-DISEASE; RECEPTOR-ALPHA CHAIN; BLOOD-BRAIN-BARRIER; BETA-TRACE PROTEIN; LONG-TERM RESCUE; MDX MICE;

D O I：

10.1089/nat.2013.0461

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Alternative splicing is an important regulator of the transcriptome. However, mutations may cause alteration of splicing patterns, which in turn leads to disease. During the past 10 years, exon skipping has been looked upon as a powerful tool for correction of missplicing in disease and progress has been made towards clinical trials. In this review, we discuss the use of antisense oligonucleotides to correct splicing defects through exon skipping, with a special focus on diseases affecting the nervous system, and the latest stage achieved in its progress.

引用

页码：69 / 86

页数：18

共 133 条

[41] Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucteotide [J].

Fletcher, S ;

Honeyman, K ;

Fall, AM ;

Harding, PL ;

Russell, J ;

Wilton, SD .

JOURNAL OF GENE MEDICINE, 2006, 8 (02) :207-216

[42] In vivo tumor growth inhibition and biodistribution studies of locked nucleic acid (LNA) antisense oligonucleotides [J].

Fluiter, K ;

ten Asbroek, ALMA ;

de Wissel, MB ;

Jakobs, ME ;

Wissenbach, M ;

Olsson, H ;

Olsen, O ;

Oerum, H ;

Baas, F .

NUCLEIC ACIDS RESEARCH, 2003, 31 (03) :953-962

[43]

Friedman JM, 1999, AM J MED GENET, V89, P1

[44] Pelizaeus-Merzbacher disease: Genetic and cellular pathogenesis [J].

Garbern, J. Y. .

CELLULAR AND MOLECULAR LIFE SCIENCES, 2007, 64 (01) :50-65

[45] Morpholino antisense oligonucleotide induced dystrophin exon 23 skipping in mdx mouse muscle [J].

Gebski, BL ;

Mann, CJ ;

Fletcher, S ;

Wilton, SD .

HUMAN MOLECULAR GENETICS, 2003, 12 (15) :1801-1811

[46] Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy [J].

Goemans, Nathalie M. ;

Tulinius, Mar ;

van den Akker, Johanna T. ;

Burm, Brigitte E. ;

Ekhart, Peter F. ;

Heuvelmans, Niki ;

Holling, Tjadine ;

Janson, Anneke A. ;

Platenburg, Gerard J. ;

Sipkens, Jessica A. ;

Sitsen, J. M. Ad ;

Aartsma-Rus, Annemieke ;

van Ommen, Gert-Jan B. ;

Buyse, Gunnar ;

Darin, Niklas ;

Verschuuren, Jan J. ;

Campion, Giles V. ;

de Kimpe, Sjef J. ;

van Deutekom, Judith C. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (16) :1513-1522

[47] β-trace protein in human cerebrospinal fluid:: a diagnostic marker for N-glycosylation defects in brain [J].

Grünewald, S ;

Huyben, K ;

de Jong, JGN ;

Smeitink, JAM ;

Rubio, E ;

Boers, GHJ ;

Conradt, HS ;

Wendel, U ;

Wevers, RA .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1999, 1455 (01) :54-60

[48] Neurofibromatosis Type 1: Modeling CNS Dysfunction [J].

Gutmann, David H. ;

Parada, Luis F. ;

Silva, Alcino J. ;

Ratner, Nancy .

JOURNAL OF NEUROSCIENCE, 2012, 32 (41) :14087-14093

[49] In vivo comparison of 2′-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping [J].

Heemskerk, Hans A. ;

de Winter, Christa L. ;

de Kimpe, Sjef J. ;

van Kuik-Romeijn, Petra ;

Heuvelmans, Niki ;

Platenburg, Gerard J. ;

van Ommen, Gert-Jan B. ;

van Deutekom, Judith C. T. ;

Aartsma-Rus, Annemieke .

JOURNAL OF GENE MEDICINE, 2009, 11 (03) :257-266

[50] A PLP splicing abnormality is associated with an unusual presentation of PMD [J].

Hobson, GM ;

Huang, Z ;

Sperle, K ;

Stabley, DL ;

Marks, HG ;

Cambi, F .

ANNALS OF NEUROLOGY, 2002, 52 (04) :477-488

← 1 2 3 4 5 6 7 8 9 10 →